Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | REGN | BMY | GSK | ||
| Company | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company | Gsk Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | ||
| Open | 905.66 | 49.16 | 40.66 | ||
| High | 912.74 | 49.47 | 41.26 | ||
| Low | 903.83 | 48.96 | 40.60 | ||
| Last | 907.32 | 48.99 | 41.24 | ||
| Change | +7.16 | -0.15 | +0.65 | ||
| % Change | +0.80% | -0.31% | +1.60% | ||
| Volume | 341,200 | 9,153,200 | 2,289,800 | ||
| 20-Day Average Volume | 442,475 | 10,953,850 | 2,989,370 | ||
| Previous Close | 900.16 | 49.14 | 40.59 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 929.14 | 50.55 | 41.06 | ||
| 20-Day Raw Stochastic | 19.57% | 20.04% | 51.29% | ||
| 20-Day Relative Strength | 39.70% | 41.71% | 50.58% | ||
| Weighted Alpha | +14.00 | -25.74 | +16.76 | ||
| Today's Opinion | 24% Buy | 88% Sell | 56% Buy | ||
| Previous Opinion | 24% Buy | 88% Sell | 40% Buy | ||
| Last Month's Opinion | 80% Buy | 24% Sell | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.47% since 04/16/24 | +1.51% since 04/16/24 | +3.23% since 04/16/24 | ||
| Low | 891.46 on 04/19/24 | 47.62 on 04/18/24 | 39.15 on 04/18/24 | ||
| High | 920.73 on 04/19/24 | 49.56 on 04/22/24 | 41.26 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | -6.19% since 03/22/24 | -5.66% since 03/22/24 | -2.62% since 03/22/24 | ||
| Low | 890.43 on 04/16/24 | 47.62 on 04/18/24 | 39.15 on 04/18/24 | ||
| High | 976.75 on 03/27/24 | 54.47 on 03/28/24 | 43.45 on 03/25/24 | ||
| 3-Month | |||||
| %Chg | -4.95% since 01/23/24 | -2.25% since 01/23/24 | +4.99% since 01/23/24 | ||
| Low | 890.43 on 04/16/24 | 47.58 on 02/06/24 | 38.56 on 01/25/24 | ||
| High | 998.33 on 02/28/24 | 55.03 on 03/13/24 | 43.84 on 03/07/24 | ||
| 6-Month | |||||
| %Chg | +14.05% since 10/23/23 | -12.52% since 10/23/23 | +15.20% since 10/23/23 | ||
| Low | 769.19 on 10/27/23 | 47.58 on 02/06/24 | 33.67 on 11/02/23 | ||
| High | 998.33 on 02/28/24 | 56.77 on 10/25/23 | 43.84 on 03/07/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 98,803,360 | 99,594,944 | 84,120,336 | ||
| Shares Outstanding, K | 109,762 | 2,026,759 | 2,072,440 | ||
| Annual Sales | 13,117,200,000 | 45,006,000,000 | 37,725,000,000 | ||
| Annual Net Income | 3,953,600,000 | 8,025,000,000 | 6,129,940,000 | ||
| Last Quarter Sales | 3,434,300,000 | 11,477,000,000 | 9,980,060,000 | ||
| Last Quarter Net Income | 1,159,600,000 | 1,762,000,000 | 433,200,000 | ||
| 60-Month Beta | 0.11 | 0.39 | 0.64 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 11.86 on 02/02/24 | 1.70 on 02/02/24 | 0.72 on 01/31/24 | ||
| Latest Earnings Date | 05/02/24 | 04/25/24 | 05/01/24 | ||
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 0.397 on 02/22/24 | ||
| Next Ex-Dividends Date | N/A | 04/04/24 | 02/22/24 | ||
| Ratios | |||||
| Price/Earnings ttm | 23.86 | 6.52 | 10.32 | ||